Clinical Trial Update: US Ovulation Inhibition Study in Obese Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating ovulation inhibition in obese women for contraception.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Snippet

Sponsor: Bayer | Conditions: Contraception | Phase 2 | Status: COMPLETED